Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized DBS Target Optimization for Treating Depression
NCT06784388Phase 1Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jan 2025
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in treatment-resistant depression (TRD), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Hamilton Rating Scale for Depression at 442 days. Started Jan 2025; status: recruiting.
02
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on NCT06784388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06784388.